Global Retirement Partners’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Global Retirement Partners’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,500	Closed	-$23.3K	–	3284
2023 Q1	$23.3K	Hold	4,500	–	–	﹤0.01%	1567
2022 Q4	$27K	Hold	4,500	–	–	﹤0.01%	1352
2022 Q3	$22K	Hold	4,500	–	–	﹤0.01%	1360
2022 Q2	$27K	Hold	4,500	–	–	﹤0.01%	1236
2022 Q1	$23K	Buy	+4,500	New	+$13.4K	﹤0.01%	1313

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Global Retirement Partners's CTIC Position: Q2 2023 in Review

Global Retirement Partners sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 4,500 shares — an estimated $23.3K sold.

Global Retirement Partners first reported a position in CTIC in Q1 2022 and held it in 5 quarters. The position peaked at $27K in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Global Retirement Partners reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Global Retirement Partners sold 4,500 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $23.3K.
Global Retirement Partners first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2022 and held it in 5 quarters.
Global Retirement Partners's CTI BioPharma Corp. (DE) Common Stock position peaked at $27K in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Global Retirement Partners's 13F filing for Q2 2023, filed 20 Jul 2023.